Effects of fish-oil constituents and plasma lipids on fibrinolysis in vitro

British Journal of Biomedical Science

Volumn 57, Issue 4, 2000, Pages 273-280

  Al Awadhi, Anwaar M ^a,b   Dunn, Christopher D R ^a  

^a UNIVERSITY OF THE WEST OF ENGLAND   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Cardiovascular diseases; Fibrinolysis; Fish oils; Lipids blood

Indexed keywords

ALTEPLASE; DOCOSAHEXAENOIC ACID; ETAMSYLATE; FISH OIL; HEMOSTATIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ICOSAPENTAENOIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRANEXAMIC ACID;

ARTICLE; BLOOD CLOT LYSIS; DIETARY INTAKE; DOSE RESPONSE; DRUG EFFECT; FIBRIN CLOT; FIBRINOLYSIS; IN VITRO STUDY; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; PRIORITY JOURNAL;

ANIMALS; DOCOSAHEXAENOIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; EICOSAPENTAENOIC ACID; FIBRINOLYSIS; FISH OILS; HUMANS; LIPIDS;

EID: 0034493048     PISSN: 09674845     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Goodnight SH. The fish oil puzzle. Sci Med 1996; 3:42-51.
2. Kromhout D, Bosschieter EB, Coulander CD. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. New Engl J Med 1985; 312:1205-9.
3. Burr ML, Gilbert JF, Holliday RM et al. Effects of changes in fat, fish, and either fibre intakes on death and myocardial reinfarction - Diet and Reinfarction Trial (DART). Lancet 1989; 2:757-61.
4. Ascherio A, Rimm EB, Stampfer MJ, Giovannucci EL, Willett WC. Dietary intake of marine n-3 fatty acids, fish intake, and the risk of coronary heart disease among men. New Engl J Med 1995; 332:977-82.
5. Goodnight SH, Harris WS, Connor WE. The effects of dietary omega-3 fatty acids on platelet composition and function in man - a prospective, controlled study. Blood 1981; 58:880-5.
6. Mishkel GJ, Cairns JA. Cardiovascular effects of omega-3 polyunsaturated fatty acids (fish oils). Bailliere's Clin Haematol 1990; 3:625-45.
7. Goodnight SH. Mechanisms of the antithrombotic effects of fish oil. Bailliere's Clin Haematol 1990; 3:601-23.
8. Nieuwenhuys CM, Beguin MS, Offermans RF, Emeis JJ, Hornstra J, Heemskerk JW. Hypocoagulant and lipid-lowering effects of dietary n-3 polyunsaturated fatty acids with unchanged platelet activation in rats. Arterioscl Thromb Vasc Biol 1998; 18: 1480-9.
9. Heemsherk JW, Vossen RC, van Dam-Mieras MC. Polyunsaturated fatty acids and function of platelets and endothelial cells. Curr Opin Lipidol 1996; 7:24-9.
10. Shiina T, Terano T, Saito J, Tamura Y, Yoshida S. Eicosapentaenoic acid and docosahexaenoic acid suppress the proliferation of vascular smooth muscle cells. Atherosclerosis 1993; 104:95-103.
11. Chu AJ, Moore J, Sampsell RN. Daily supplementation with MaxEPA suppresses endotoxin-induced monocytic procoagulation in dogs. J Surg Res 1997; 71:93-9.
12. Davis HR, Bridenstine RT, Vesselinovitch D, Wissler RW. Fish oil inhibits development of atherosclerosis in Rhesus monkeys. Arteriosclerosis 1987; 7:441-9.
13. Connor SL, Connor WE. Are fish oils beneficial in the prevention and treatment of coronary artery disease? Am J Clin Nutr 1997; 66(suppl 4):1020s-31s.
14. Bihain BE, Delplanque B, Khallou J et al. Lipolysis-stimulated receptor: a newcomer on the lipoprotein research scene. Diabetes Metab 1995; 21:121-6.
15. Malyszko JS, Malyszko J, Pawlak K, Mysliwiec M. Effect of treating glomerulonephritis with omega-3 fatty acids for selected parameters of homostasis, platelet function and lipid metabolism. Przeglad Lekarski 1996; 53:600-3 (in Polish).
16. Leu CS, Mclaren M, Belch JJ. Effects of fish oil on plasma fibrinolysis in patients with rheumatoid arthritis. Clin Experta Rheumatol 1995; 13:87-90.
17. Schmidt EB, Nielsen LK, Pedersen JO, Kornerup HJ, Dyerberg J. The effect of n-3 polyunsaturated fatty acids on lipids, platelet function, coagulation, fibrinolysis and monocyte chemotaxis in patients with hypertension. Clin Chim Acta 1990; 189:25-32.
18. Knapp HR, Dietary fatty acids in human thrombosis and hemostasis. Am J Clin Nutr 1997; 65(suppl 5):1687s-98s.
19. Toft I, Bonna KH, Ingeberesten OC, Norday A, Jenseen T. Fibrinolytic function after dietary supplementation with omega-3 polyunsaturated fatty acids. Atheroscler Thromb Vasc Biol 1997; 17:814-9.
20. Brown AJ, Roberts DC. Fish and fish oil intake: effects on haematological variables related to cardiovascular disease. Thromb Res 1991; 64:169-78.
21. Tsuruta K, Ogawa H, Yasue H et al. Effect of purified eicosapentaenoate ethyl ester on fibrinolytic capacity in patients with stable coronary artery disease and lower extremity ischaemia, Coronary Artery Dis 1996; 7:837-42.
22. Barcelli U, Glas-Greenwalt P, Pollack VE, Enhancing effect of dietary supplementation with n-3 fatty acids on plasma fibrinolysis in normal subjects. Thromb Res 1985; 39:307-12.
23. Mehta J, Lawson D, Saldeen TJ. Reduction in plasminogen activator inhibitor-1 (PAI-I) with omega-3 polyunsaturated fatty acids (PUFA) intake. Am Heart J 1988; 116:1201-6.
24. Longstaff C. Studies on the mechanism of action of aprotinin and tranexamic acid as plasmin inhibitors and antifibrinolytic agents. Blood Coag Fibrinol 1994; 5:537-42.
25. th edn. London: Churchill Livingstone, 1995.
26. Bonnar J, Sheppard BL. Treatment of menorrhagia during menstruation: randomised controlled trial of ethamsylate, mefenamic acid, and tranexamic acid. BMJ 1996; 313:579-82.
27. Marcantoni JP, Biason P. Atheroma and fish oils. Arch Maladies Coeur Vaisseaux 1992; 85(spec 2):175-80 (in French).
28. British National Formulary. London: British Medical Association and the Royal Pharmaceutical Society of Great Britain, March 2000:114-5.
29. Emeis JJ, Van Houwelingen AC, Van Den Hoogen CM, Hornstra G. A moderate fish intake increases plasminogen activator inhibitor type-1 in human volunteers. Blood 1989; 74:233-7.
30. Takimoto G, Galang J, Lee GK, Bradlow BA. Plasma fibrinolytic activity after ingestion of omega-3 fatty acids in human subjects. Thromb Res 1989; 54:573-82.
31. Grundt H, Nilsen DW, Hetland O, Mansoor MA, Aarsland T, Woie L. Atherothrombogenic risk modulation by n-3 fatty acids was not associated with changes in homocysteine in subjects with combined hyperlipidaemia. Thromb Haemostasis 1999; 81:561-5.
32. Andriamampandry MD, Leray C, Freund M, Cazenave JP, Gachet C. Antithrombotic effects of (n-3) polyunsaturated fatty acids in rat models of arterial and venous thrombosis. Thromb Res 1999; 93:9-16.
33. Rosenson RS, Lowe GD, Effects of lipids and lipoproteins on thrombosis and rheology. Atherosclerosis 1998; 140:271-80.
34. Zhang J, Ren S, Sun D, Shen GX. Influence of glycation on LDL-induced generation of fibrinolytic regulators in vascular endothelial cells. Arterioscler Thromb Vasc Res 1998; 18:1140-8.
35. Tremoli E, Camera M, Maderna P et al. Increased synthesis of plasminogen activator inhibitor-1 by cultured human endothelial cells exposed to native and modified LDLs. An LDL receptor-independent phenomenon. Arterioscl Thromb Vasc Biol 1993; 13:338-46.